pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 14·1 min read
save

#ASGCT26 dispatch: In vivo CAR-T is everywhere

BOSTON — Greetings from Boston, where I’ve been on the ground covering the American Society of Gene & Cell Therapy’s annual meeting all week. It’s a crucial moment for the field. Genetic medicine developers haven’t recovered ...

May 14, 2026·read at Endpoints ↗

Outside the ASGCT conference (Ryan Cross for Endpoints News) May 14, 2026 02:24 PM EDT Cell/Gene TxFDA+ AS­GCT dis­patch: In vi­vo CAR-T is every­where Ryan Cross Senior Science Correspondent BOSTON — Greet­ings from Boston, where I’ve been on the ground cov­er­ing the Amer­i­can So­ci­ety of Gene & Cell Ther­a­py’s an­nu­al meet­ing all week. It’s a … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
90 words · retrieved May 14
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
DisPATCH
topics
CAR-T2Cell Therapy

related stories

  • Aug 27CAR Ts will only treat autoimmune diseases if we can scale deliveryBioSpace
  • Aug 26BMS ends Cellares pact over cell therapy production problems, triggering layoffsBioSpace
  • Aug 17J&J hands lymphoma bispecific CAR T back to AbelZetaBioSpace
  • Aug 14After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?Fierce Biotech
  • Aug 12Boulevard starts up with $65M to pursue targeted autoimmune drugsBioPharma Dive